Point72 Asia (Singapore) Pte. Ltd. Adaptive Biotechnologies Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,522 shares of ADPT stock, worth $21,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,522Holding current value
$21,235% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
224Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$253 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$123 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$98.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$90.2 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$79.4 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.2B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...